Olanzapine for the treatment of chronic refractory schizophrenia: a 12-month follow-up naturalistic study. [electronic resource]
- Progress in neuro-psychopharmacology & biological psychiatry Oct 2002
- 1055-62 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
0278-5846
10.1016/s0278-5846(02)00222-1 doi
Antipsychotic Agents--adverse effects Basal Ganglia Diseases--chemically induced Benzodiazepines Body Weight--drug effects Chronic Disease Drug Resistance Female Follow-Up Studies Humans Male Middle Aged Olanzapine Pirenzepine--adverse effects Psychiatric Status Rating Scales Schizophrenia--drug therapy